Clinical Trials in Minneapolis

Showing 10461-10480 of 14,456 trials

TRX4 Monoclonal Antibody in Type 1 Diabetes (T1 DM)

NCT00451321

The purpose of this study is to optimize several multi-dose regimens of otelixizumab, determine the highest biologically active dose, evaluate biomarkers and surrogates of efficacy, and to evaluate the effects of each multi-dose regimen of otelixizumab against standard safety and efficacy parameters.

Diabetes Mellitus, Type 1

GlaxoSmithKline88 participantsStarted Jul 2006

Birmingham, Alabama, United States • Walnut Creek, California, United States • Aurora, Colorado, United States +14 more locations

COMPLETED< 1 mile

Extended Follow-Up After Islet Transplantation in T1D

NCT01369082

The purpose of this study is to provide patients who have received at least one islet transplant as a previous participant in a Clinical Islet Transplantation Consortium (CIT) clinical trial with maintenance immunosuppressive medications and to collect information about the safety of the medications and islet function.

Type 1 Diabetes (T1D)Islet Transplantation

National Institute of Allergy and Infectious Diseases (NIAID)75 participantsStarted May 2011

San Francisco, California, United States • Miami, Florida, United States • Atlanta, Georgia, United States +5 more locations

TRX4 Monoclonal Antibody in Type 1 Diabetes (T1 DM)

Extended Follow-Up After Islet Transplantation in T1D

Find Trials by Condition in Minneapolis

A Study to Evaluate the Efficacy and Safety of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Protein, Amino Acids & Insulin & Glucagon Secretion in Humans

Study Of SB-497115 in Healthy Subjects and Subjects With Mild, Moderate or Severe Renal Impairment

Fluticasone Propionate/Salmeterol Combination 250/50 DISKUS in the Exercise Endurance Time in Patients With Chronic Obstructive Pulmonary Disease

Evaluating the Efficacy and Safety of Fluticasone Furoate Inhalation Powder in the Treatment of Asthma in Adults and Adolescents

Effectiveness of the Optifast Program Compared With a Reduced-energy Food Based Diet Plan on Body Weight

Single Dose Intravesical Apaziquone Postoperative in Patients Undergoing TURBT for Noninvasive Bladder Cancer (SPI-612)

S0601 Rituximab, Combination Chemotherapy, and Bortezomib Followed by Bortezomib Alone in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma

A Multiple Dose Study Of PF-04950615 (RN316) In Subjects On Maximum Doses Of Statins

A Phase IIIb Study to Evaluate the Efficacy of Umeclidinium/Vilanterol (UMEC/VI) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Study to Evaluate the 24-Hour Pulmonary Function Profile of Fluticasone Furoate (FF) /GW642444 (Vilanterol) (VI) Inhalation Powder 100/25mcg Once Daily Compared With Fluticasone Propionate/Salmeterol Inhalation Powder 250/50mcg Twice Daily in Subjects With Chronic Obstructive Pulmonary Disease

A Pharmacokinetics Study of the Effects of GSK2118436 on Warfarin, the Effects of Ketoconazole and Gemfibrozil on GSK2118436, and the Effects of Repeat Doses of GSK2118436 in Subjects With BRAF Mutant Solid Tumors

Study B2C112060: A Study of the Efficacy and Safety of Vilanterol Inhalation Powder in Adults and Adolescents With Persistent Asthma

Oblimersen and Doxorubicin in Treating Patients With Advanced Hepatocellular Carcinoma (Liver Cancer)

Safety and Tolerability Study of GSK1120212, a MEK Inhibitor, in Combination With Docetaxel, Erlotinib, Pemetrexed, Pemetrexed + Carboplatin, Pemetrexed + Cisplatin, or Nab-Paclitaxel

A Study of the GSK MEK Inhibitor GSK1120212 and Everolimus in Cancer Subjects

A Study of EDP-305 in Subjects With Mild and Moderate Hepatic Impairment Compared With Normal Healthy Volunteers

Fractional Flow Reserve Versus Angiography for Multivessel Evaluation (F.A.M.E.)